石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

已收盘 01-05 16:08:54

8.890

+0.410

+4.83%

最高8.940	最低8.380	成交量1.73亿
今开8.490	昨收8.480	日振幅6.60%
总市值1,024亿	流通市值1,024亿	总股本115.22亿
成交额15.22亿	换手率1.50%	流通股本115.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":8.89,"timestamp":1767600534002,"preClose":8.48,"halted":0,"volume":172606636,"delay":0,"floatShares":11522000000,"shares":11522000000,"eps":0.4113055679140221,"marketStatus":"已收盘","change":0.41,"latestTime":"01-05 16:08:54","open":8.49,"high":8.94,"low":8.38,"amount":1522219841,"amplitude":0.066038,"askPrice":8.89,"askSize":234000,"bidPrice":8.88,"bidSize":438000,"shortable":3,"etf":0,"ttmEps":0.3951609113352284,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767663000000},"marketStatusCode":5,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":8.48,"dividendRate":0.026974,"openAndCloseTimeList":[[1767576600000,1767585600000],[1767589200000,1767600000000]],"volumeRatio":1.37146,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":false,"expireDate":1769616000000,"strike":"8.25","timestamp":1767577762343,"price":0.2,"volume":245,"amount":98000,"type":"*"},{"symbol":"CSP.HK","call":true,"expireDate":1769616000000,"strike":"9.00","timestamp":1767589523787,"price":0.43,"volume":220,"amount":189200,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4927,"impliedVolPercentile":0.4187},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"1145697823","title":"石药集团（01093）更新12月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1145697823","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145697823?lang=zh_cn&edition=full","pubTime":"2026-01-02 19:50","pubTimestamp":1767354658,"startTime":"0","endTime":"0","summary":"石药集团有限公司（01093）于2026年1月2日披露2025年12月股份变动月报表，报告期为2025年12月1日至2025年12月31日。公告显示，截至本月末，公司已发行股份总数维持在11,522,451,732股，未见新增发行或回购注销活动，库存股份亦维持为零。公司股本结构在本报告期内保持稳定。\n根据月报信息，石药集团在此前已设立的2015年购股权计划项下依旧保留1,300,000份未行使期权，未有新增行使或失效记录。公告同时说明，公司于报告期内未签订其他可兑换或认股协议。公司方面称，将继续遵守香港联合交易所有限公司相关规定。\n上述公告由公司秘书罗泰安于2026年1月2日签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"gpt_icon":0},{"id":"2600068992","title":"石药集团(01093)：乙磺酸尼达尼布吸入粉雾剂在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2600068992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600068992?lang=zh_cn&edition=full","pubTime":"2026-01-02 19:48","pubTimestamp":1767354513,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的乙磺酸尼达尼布吸入粉雾剂已获中国国家药品监督管理局批准，可在中国开展临床试验。该产品为首个在国内获批临床用于治疗肺纤维化的吸入制剂。乙磺酸尼达尼布是多重酪氨酸激酶抑制剂，能够延缓特发性肺纤维化进程，目前上市的剂型为口服软胶囊。本次获批的临床适应症为特发性肺纤维化。该产品是集团吸入技术平台的重要成果，其临床试验获批为管线内后续吸入制剂的开发奠定了良好基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：乙磺酸尼达尼布吸入粉雾剂在中国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1008478684.HKD","01093","IE00B543WZ88.USD","LU1226287875.USD","LU1328277881.USD","LU1226287792.SGD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1960683339.HKD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1813983027.USD","LU1951186391.HKD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1993786604.SGD","LU2039709279.SGD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU1807302812.USD","HK0000165453.HKD","LU1226287529.USD","LU0072913022.USD","LU1152091754.HKD","SG9999004220.SGD","LU0880133367.SGD","BK1515","LU0067412154.USD","IE0008368742.USD","LU1152091168.USD","BK1191","LU0140636845.USD","BK1521","LU0315179316.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2600809145","title":"1月2日港股药品及生物科技行业沽空数据盘点，晶泰控股、石药集团、药明生物沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2600809145","media":"证券之星APP","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600809145?lang=zh_cn&edition=full","pubTime":"2026-01-02 18:06","pubTimestamp":1767348394,"startTime":"0","endTime":"0","summary":"当日药品及生物科技行业总体涨1.45%。从沽空金额来看，晶泰控股、石药集团、药明生物沽空金额位居行业前三，分别为1.13亿港元、9764.43万港元、9160.72万港元。从沽空比例偏离度来看，海普瑞、药师帮、晶泰控股沽空比例偏离度位居行业前三，分别为637.84%、546.76%、261.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102181745a6eb6366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102181745a6eb6366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0315179316.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0979878070.USD","LU0856984785.SGD","LU0417516738.SGD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1993786604.SGD","LU1152091168.USD","LU0326950275.SGD","LU0516423174.USD","LU1226287792.SGD","LU0051755006.USD","02228","IE0008368742.USD","LU0181495838.USD","LU0708995583.HKD","LU1226288253.USD","LU1720050803.USD","LU0043850808.USD","LU1226287529.USD","IE00B5MMRT66.SGD","BK1515","LU0072913022.USD","LU1008478684.HKD","LU1152091754.HKD","LU1813983027.USD","LU0516422952.EUR","IE00BZ08YT58.USD","BK1576","LU0052750758.USD","LU0307460666.USD","LU0348735423.USD","LU1807302812.USD","LU0359202008.SGD","LU0823426308.USD","LU0359201612.USD","BK1617","LU0067412154.USD","LU1242518931.SGD","IE0008369823.USD","SG9999002463.SGD","LU0456846285.SGD","LU0456827905.SGD","LU0588546209.SGD","02269","01093","LU0348825331.USD"],"gpt_icon":0},{"id":"2600914920","title":"每日卖空追踪 | 石药集团 01月02日卖空量成交397.4万股，卖空比例为10.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600914920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600914920?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342619,"startTime":"0","endTime":"0","summary":"石药集团北京时间01月02日，涨0.59%，卖空量成交397.4万股，较上一交易日减少84.77%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163201a6eb2927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163201a6eb2927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288170.HKD","IE0008369823.USD","LU1960683339.HKD","LU0315179316.USD","IE00BZ08YR35.GBP","LU1226288253.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287875.USD","HK0000165453.HKD","LU0326950275.SGD","LU1807302812.USD","LU0140636845.USD","LU1226287792.SGD","LU1328277881.USD","LU1993786604.SGD","BK1515","SG9999004220.SGD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1008478684.HKD","LU0314109678.HKD","LU0067412154.USD","LU2039709279.SGD","LU1813983027.USD","LU0880133367.SGD","LU1951186391.HKD","IE00B031HY20.USD","LU1152091168.USD","BK1191","BK1521","IE00B5MMRT66.SGD","LU1226287529.USD","IE0008368742.USD","01093"],"gpt_icon":0},{"id":"2600034057","title":"每日卖空追踪 | 石药集团 12月31日卖空量成交2609万股，卖空比例为34.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600034057","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600034057?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169818,"startTime":"0","endTime":"0","summary":"石药集团北京时间12月31日，跌0.82%，卖空量成交2609万股，较上一交易日减少50.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163230a48dc53c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163230a48dc53c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","LU1008478684.HKD","LU1152091168.USD","LU0067412154.USD","LU1951186391.HKD","SG9999004220.SGD","LU1328277881.USD","LU0315179316.USD","LU0880133367.SGD","LU0140636845.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0072913022.USD","LU1226287875.USD","IE00B031HY20.USD","LU1152091754.HKD","LU1807302812.USD","01093","BK1521","BK1515","LU0501845795.SGD","LU1993786604.SGD","LU1226288253.USD","IE0008368742.USD","IE00B543WZ88.USD","LU1813983027.USD","LU1226287529.USD","IE00BZ08YR35.GBP","BK1191","IE0008369823.USD","IE00B5MMRT66.SGD","LU1226287792.SGD","HK0000165453.HKD","LU0326950275.SGD","LU2039709279.SGD","LU1226288170.HKD","LU0314109678.HKD"],"gpt_icon":0},{"id":"2600424703","title":"石药集团SYHX1901片启动Ⅰ期临床 适应症为中重度斑块状银屑病、非节段型白癜风、重度斑秃","url":"https://stock-news.laohu8.com/highlight/detail?id=2600424703","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600424703?lang=zh_cn&edition=full","pubTime":"2025-12-31 12:31","pubTimestamp":1767155460,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，石药集团欧意药业有限公司的在健康受试者中评估SYHX1901与瑞舒伐他汀、雷贝拉唑、伊曲康唑和利福平的药物相互作用研究已启动。SYHX1901片为化学药物，适应症为中重度斑块状银屑病、非节段型白癜风、重度斑秃。中重度斑块状银屑病表现为边界清晰红斑、鳞屑；非节段型白癜风是皮肤黏膜色素脱失斑；重度斑秃则是突然出现的片状脱发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231123257a6e3f4e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231123257a6e3f4e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU0072913022.USD","LU0315179316.USD","LU1152091168.USD","LU0140636845.USD","LU1226288253.USD","LU1152091754.HKD","LU1960683339.HKD","LU1328277881.USD","LU0314109678.HKD","BK1521","LU2039709279.SGD","LU1226288170.HKD","LU1226287875.USD","IE00B543WZ88.USD","BK1515","LU0501845795.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00BZ08YS42.EUR","BK1191","LU1226287792.SGD","IE0008369823.USD","LU1813983027.USD","LU1993786604.SGD","LU0880133367.SGD","LU1951186391.HKD","01093","LU1008478684.HKD","IE00B031HY20.USD","HK0000165453.HKD","IE0008368742.USD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0067412154.USD","LU1226287529.USD","LU1807302812.USD"],"gpt_icon":0},{"id":"2600032637","title":"石药集团创新药大突破：降糖新复方、减重双靶点、降压新策略齐获临床批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2600032637","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600032637?lang=zh_cn&edition=full","pubTime":"2025-12-31 11:22","pubTimestamp":1767151352,"startTime":"0","endTime":"0","summary":"12月29日晚，石药集团发布公告，其三大创新药物同步获得临床试验批件，覆盖糖尿病、减重、高血压三大热门治疗领域。结语石药集团此次三大创新药同期获批临床，标志着其在代谢疾病和心血管疾病领域的研发实力已进入加速阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231112312a6e3b8f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231112312a6e3b8f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","LU1993786604.SGD","HK0000165453.HKD","BK1161","IE00B5MMRT66.SGD","LU0880133367.SGD","LU0140636845.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU1813983027.USD","LU0067412154.USD","LU0314109678.HKD","LU1226288170.HKD","IE0008368742.USD","LU0501845795.SGD","LU1807302812.USD","BK1521","LU0315179316.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU1152091168.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1226288253.USD","SG9999004220.SGD","LU0326950275.SGD","BK1574","LU1960683339.HKD","01093","IE00BZ08YS42.EUR","06978","LU1152091754.HKD","LU1226287875.USD","LU1951186391.HKD","LU1226287529.USD","LU2039709279.SGD","LU1226287792.SGD","LU1328277881.USD","IE0008369823.USD"],"gpt_icon":0},{"id":"1177614902","title":"石药集团GLP-1/GIP受体双重偏向激动剂多肽注射液获中国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1177614902","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177614902?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:32","pubTimestamp":1767004364,"startTime":"0","endTime":"0","summary":"石药集团宣布，其自主研发的GLP-1/GIP受体双重偏向激动剂多肽注射液（研发代号：SYH2069注射液）已正式获得中国国家药品监督管理局的临床试验批准。\n该注射液作为新型降糖药物，通过双重激活GLP-1和GIP受体，有望在血糖控制与体重管理方面展现协同增效作用。此次获批标志着石药集团在代谢性疾病创新药研发领域取得重要进展，为后续临床研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368742.USD","LU1807302812.USD","LU2039709279.SGD","LU1226287792.SGD","BK1515","LU0067412154.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1226288170.HKD","IE00B031HY20.USD","LU0880133367.SGD","LU1993786604.SGD","SG9999004220.SGD","LU0314109678.HKD","LU1226287875.USD","LU1328277881.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1226288253.USD","LU0140636845.USD","LU0072913022.USD","01093","IE00BZ08YR35.GBP","HK0000165453.HKD","BK1521","LU1813983027.USD","LU1152091168.USD","LU0501845795.SGD","BK1191","LU1226287529.USD","IE00BZ08YT58.USD","LU1960683339.HKD","LU0315179316.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2595813917","title":"石药集团(01093)：GLP -1 / GIP受体双偏向性激动多肽注射液(SYH2069注射液)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2595813917","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595813917?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:24","pubTimestamp":1767003869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的GLP -1 / GIP受体双偏向性激动多肽注射液已获得中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。非人灵长类重复给药毒理研究显示，该产品耐受性良好，未观察到任何呕吐及胃肠道不良反应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0315179316.USD","LU1008478684.HKD","LU0326950275.SGD","LU1226288253.USD","IE0008369823.USD","LU0140636845.USD","LU1152091754.HKD","LU1226288170.HKD","LU1960683339.HKD","LU1152091168.USD","LU1951186391.HKD","BK1515","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","LU1813983027.USD","01093","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU2039709279.SGD","LU0314109678.HKD","LU1328277881.USD","BK4590","BK4144","LU0067412154.USD","BK1521","GLP","BK1191","LU0501845795.SGD","LU1226287875.USD","SG9999004220.SGD","IE00B031HY20.USD","LU0880133367.SGD","LU1993786604.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","IE0008368742.USD"],"gpt_icon":0},{"id":"2595753647","title":"12月29日港股药品及生物科技行业沽空数据盘点，石药集团、中国生物制药、药明康德沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2595753647","media":"证券之星APP","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595753647?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:06","pubTimestamp":1767002774,"startTime":"0","endTime":"0","summary":"当日药品及生物科技行业总体跌1.99%。从沽空金额来看，石药集团、中国生物制药、药明康德沽空金额位居行业前三，分别为3.61亿港元、9781.28万港元、9343.58万港元。从沽空比例来看，和铂医药-B、石四药集团、石药集团沽空比例位居行业前三，分别为36.39%、33.24%、31.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229181402a485adeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229181402a485adeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","01177","LU2242644610.SGD","LU1807302812.USD","LU0052750758.USD","SG9999004220.SGD","IE0008369823.USD","BK1576","LU1226288170.HKD","LU1328277881.USD","BK1141","LU0140636845.USD","IE00B031HY20.USD","LU1226287792.SGD","LU1046422090.SGD","LU1152091168.USD","LU0067412154.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1521","IE00BZ08YS42.EUR","LU0320764599.SGD","LU2125910500.SGD","LU2039709279.SGD","LU0326950275.SGD","LU0880133367.SGD","LU1226287529.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU0501845795.SGD","LU1226288253.USD","LU0314109678.HKD","LU1813983027.USD","BK1515","LU1008478684.HKD","LU0072913022.USD","02359","BK1583","IE00BZ08YR35.GBP","BK1589","LU0315179316.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091754.HKD","LU1951186391.HKD","BK1191","LU0708995583.HKD","IE0008368742.USD","LU2045819591.USD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2595343277","title":"石药集团(01093.HK)获执行董事兼主席蔡东晨增持48.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595343277","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595343277?lang=zh_cn&edition=full","pubTime":"2025-12-29 08:47","pubTimestamp":1766969221,"startTime":"0","endTime":"0","summary":"格隆汇11月29日丨根据联交所最新权益披露资料显示，2024年11月27日，石药集团(01093.HK)获执行董事兼主席蔡东晨在场内以每股均价5.0641港元增持48.4万股，涉资约245.1万港元。\r\n\r\n　　增持后，蔡东晨最新持股数目为2,854,817,670股，持股比例由24.40%上升至24.41%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/29/20251229621525.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/29/20251229621525.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251229/31898610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1008478684.HKD","LU1152091168.USD","IE00BZ08YT58.USD","LU1328277881.USD","LU1807302812.USD","01093","LU0501845795.SGD","LU1993786604.SGD","LU1226288253.USD","LU1226287792.SGD","LU0072913022.USD","LU0326950275.SGD","LU0880133367.SGD","IE00B543WZ88.USD","LU1152091754.HKD","LU1960683339.HKD","LU0140636845.USD","HK0000165453.HKD","LU0067412154.USD","BK1515","LU1226287529.USD","SG9999004220.SGD","LU1951186391.HKD","IE00BZ08YR35.GBP","BK1521","LU0315179316.USD","LU1813983027.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","IE00B031HY20.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","IE0008369823.USD","IE0008368742.USD","LU0314109678.HKD","BK1191"],"gpt_icon":0},{"id":"2594218622","title":"瞩目，石药集团又一重磅明星药迎来新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2594218622","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594218622?lang=zh_cn&edition=full","pubTime":"2025-12-28 08:00","pubTimestamp":1766880016,"startTime":"0","endTime":"0","summary":"近日，2025年12月23日，石药集团宣布，本集团开发的达雷妥尤单抗注射液已获中国国国家药品监督管理局批准，可在中国开展临床试验。国内仿制情况，截至目前为止，达雷妥尤单抗注射液仅有原研强生拥有生产批文，暂无国内药企报产在审，杭州九源基因、正大天晴南京顺欣制药、石药集团巨石生物制药3家国内药企获批临床。尽管近年来多发性骨髓瘤的治疗取得了诸多进展，但多数患者仍面临复发或耐药的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228081638a6d76216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228081638a6d76216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0314109678.HKD","SG9999004220.SGD","LU1226287792.SGD","LU0315179316.USD","BK1521","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0067412154.USD","01093","LU1152091168.USD","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","LU1807302812.USD","LU1008478684.HKD","LU1226287529.USD","LU0880133367.SGD","LU1993786604.SGD","IE00B543WZ88.USD","LU1960683339.HKD","LU1152091754.HKD","LU1226288170.HKD","BK1191","IE00B5MMRT66.SGD","LU1226287875.USD","LU1328277881.USD","LU2039709279.SGD","LU0140636845.USD","LU0326950275.SGD","LU1951186391.HKD","LU1226288253.USD","IE0008368742.USD","LU0501845795.SGD","LU1813983027.USD","LU0072913022.USD","BK1515"],"gpt_icon":0},{"id":"2594226457","title":"创新药BD热后，估值“还债”中","url":"https://stock-news.laohu8.com/highlight/detail?id=2594226457","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594226457?lang=zh_cn&edition=full","pubTime":"2025-12-27 20:00","pubTimestamp":1766836823,"startTime":"0","endTime":"0","summary":"彼时，市面上甚至还有好几只年内收益翻倍的医药主题基金，BD交易频频刷屏，许多人都相信，“创新药的黄金十年”在二级市场上正在兑现。不少头部及腰部创新药企在年末连续发布了重磅的BD达成公告，交易对象不乏阿斯利康、武田、百时美施贵宝等全球制药巨头，但二级市场的反馈却时常冷淡，股价屡屡出现见光死的行情，市场情绪从期待转为疲软。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227200212a47ef53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227200212a47ef53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","02509","BK1574","BK1161","06978","01276"],"gpt_icon":0},{"id":"2594248467","title":"孟鲁司特钠警示冲击儿童用药市场，石药、扬子江等10亿级单品面临波动风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2594248467","media":"华夏时报网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594248467?lang=zh_cn&edition=full","pubTime":"2025-12-27 17:02","pubTimestamp":1766826176,"startTime":"0","endTime":"0","summary":"国家药监局一纸修订公告，一款年销售额超10亿元的止咳药站上风口浪尖。12月22日，国家药监局发布公告，要求对孟鲁司特制剂说明书进行统一修订。新增警示语明确提及“抑郁和自杀倾向”等严重神经精神不良反应，修订涵盖孟鲁司特钠片、咀嚼片、颗粒和口溶膜等所有剂型，而后三者主要为儿童专用剂型。据悉，孟鲁司特钠作为呼吸系统常用药物，尤其受到儿童患者的青睐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512273603603382.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512273603603382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1993786604.SGD","01093","LU0880133367.SGD","LU0067412154.USD","HK0000165453.HKD","BK1191","IE00B5MMRT66.SGD","LU1152091168.USD","IE0008368742.USD","IE00B543WZ88.USD","LU0140636845.USD","LU0072913022.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1807302812.USD","BK1521","BK1515","IE00B031HY20.USD","LU1226288253.USD","LU1813983027.USD","LU1226287529.USD","LU1960683339.HKD","LU1152091754.HKD","LU2039709279.SGD","LU1226287875.USD","LU0326950275.SGD","LU0315179316.USD","LU0501845795.SGD","IE0008369823.USD","LU0314109678.HKD","LU1226288170.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1951186391.HKD","LU1328277881.USD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2594325913","title":"石药创新制药股份有限公司股东会通过多项重要议案，包括变更会计师事务所及补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2594325913","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594325913?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:00","pubTimestamp":1766656800,"startTime":"0","endTime":"0","summary":"中访网数据石药创新制药股份有限公司于2025年12月25日召开了2025年第三次临时股东会。核心决策包括：同意将部分已结项的募集资金投资项目节余资金永久补充流动资金并注销相关专户；批准了公司2026年度与关联方的日常交易预计额度；决议变更公司年度审计会计师事务所；以及授权公司及子公司向银行申请2026年度综合授信额度。其中，关联交易议案因涉及关联方，相关股东已依法回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180131a6ce2687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180131a6ce2687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0326950275.SGD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1951186391.HKD","LU1813983027.USD","LU1226287875.USD","LU1226288170.HKD","SG9999004220.SGD","LU1152091754.HKD","IE00B543WZ88.USD","LU0140636845.USD","HK0000165453.HKD","LU0314109678.HKD","LU0880133367.SGD","BK1191","IE00B031HY20.USD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287529.USD","IE0008369823.USD","LU0315179316.USD","LU1152091168.USD","LU0072913022.USD","LU1960683339.HKD","01477","BK1515","LU0501845795.SGD","01093","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1521","LU2039709279.SGD","LU1226287792.SGD","BK1574","LU0067412154.USD","LU1328277881.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2594259136","title":"【瞩目】石药集团入局$100亿明星药","url":"https://stock-news.laohu8.com/highlight/detail?id=2594259136","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594259136?lang=zh_cn&edition=full","pubTime":"2025-12-25 16:45","pubTimestamp":1766652317,"startTime":"0","endTime":"0","summary":"精彩内容日前，石药集团发布公告，集团开发的达雷妥尤单抗注射液在中国获临床试验批准，用于治疗多发性骨髓瘤成年患者。石药集团表示，集团的达雷妥尤单抗注射液研发遵循生物类似药相关研究指导原则，药学及非临床研究结果显示，该产品与原研药在质量、安全性和有效性方面高度相似，支持开展后续临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225172647a4770164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225172647a4770164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0314109678.HKD","LU0072913022.USD","LU1152091168.USD","IE0008369823.USD","LU1328277881.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU2039709279.SGD","01093","IE00BZ08YT58.USD","BK1191","IE00BZ08YS42.EUR","LU0315179316.USD","LU0326950275.SGD","LU1226287529.USD","LU1226288170.HKD","BK1515","HK0000165453.HKD","LU0140636845.USD","BK1521","LU0501845795.SGD","LU1960683339.HKD","LU1226288253.USD","LU1008478684.HKD","SG9999004220.SGD","LU1993786604.SGD","IE0008368742.USD","LU0880133367.SGD","LU1226287792.SGD","IE00B543WZ88.USD","LU1226287875.USD","LU1813983027.USD","LU1951186391.HKD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0067412154.USD"],"gpt_icon":0},{"id":"2594225913","title":"抢占高潜力细分赛道，石药等药企拟设立合资公司破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2594225913","media":"制药网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594225913?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:56","pubTimestamp":1766645795,"startTime":"0","endTime":"0","summary":"无独有偶，10月30日，海正药业曾与圣兆药物签署合作协议，共同投资在台州市椒江区设立一家专注于复杂注射剂领域的合资公司。海正药业称，公司已将复杂注射剂作为实施差异化发展的重点领域，通过参与圣兆药物股票定向发行、与其投资设立合资子公司，符合公司在高端仿制领域的战略布局，有利于公司培育新的利润增长点。从行业发展趋势来看，药企设立合资公司具有深刻的行业逻辑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225145847a6cd6dd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225145847a6cd6dd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","IE0008369823.USD","LU1993786604.SGD","LU0880133367.SGD","LU0326950275.SGD","LU1226287875.USD","LU1328277881.USD","LU0315179316.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1813983027.USD","LU0072913022.USD","LU1152091754.HKD","LU0067412154.USD","LU2039709279.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1226288253.USD","LU1152091168.USD","HK0000165453.HKD","LU1951186391.HKD","BK1521","LU1226287792.SGD","IE00B031HY20.USD","IE0008368742.USD","LU1960683339.HKD","BK1191","BK1515","SG9999004220.SGD","IE00B543WZ88.USD","LU1226287529.USD","LU1807302812.USD","LU0140636845.USD","01093"],"gpt_icon":0},{"id":"2593479945","title":"智通港股通活跃成交|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593479945","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593479945?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:00","pubTimestamp":1766574001,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年12月24日当天，中芯国际、阿里巴巴-W、中国移动位居沪港通（南向）成交额前3位，成交额分别为29.39 亿元、19.46 亿元、10.41 亿元；中芯国际、阿里巴巴-W、腾讯控股 位居深港通（南向）成交额前3位，成交额分别为16.78 亿元、10.74 亿元、9.16 亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1481107354.HKD","BK4503","BK1152","SG9999014674.SGD","BK1608","LU2476274720.SGD","SG9999001226.SGD","IDCBY","LU1226288170.HKD","LU0211331839.USD","SG9999013353.USD","LU0269904917.USD","LU2265009873.SGD","SG9999002463.SGD","LU0072462343.USD","BK1615","LU0320764755.SGD","LU0786609619.USD","LU1810669033.SGD","IE0008368411.USD","IE00BMCWC346.EUR","LU0469268626.HKD","LU0261950983.USD","LU0463099449.HKD","LU0898667661.SGD","SG9999014906.USD","LU1804176565.USD","LU0823039010.USD","BK1594","LU0918141887.USD","LU0314109678.HKD","LU2257852520.SGD","SGXZ51526630.SGD","LU1868837565.USD","LU0254981946.USD","BK4502","LU0320764243.SGD","89988","LU2488822045.USD","00941","LU0589944569.HKD","BK4585","SGXZ90724238.SGD","LU0738912210.USD","LU0348816934.USD","LU0577902611.USD","BK4614","BK4587","LU0823397285.USD","HK0000306685.HKD","HK0000500386.USD","LU2097828714.EUR","LU2251237488.HKD","LU0327786744.USD","HK0000252152.HKD","SG9999018865.SGD","LU2462611646.USD","LU0553294199.USD","BK1193","LU1282649141.HKD","LU0359201885.HKD","LU0396098781.USD","LU0831093199.SGD","BK1509","BK1163","SG9999017495.SGD","IE00B067MR52.USD","LU0819123356.HKD","SG9999000327.SGD","LU1282649067.USD","SG9999001689.USD","LU1439103000.SGD","BK4558","LU0107464264.USD","LU2476274308.USD","BK4526","BK4505","SG9999015952.SGD","SG9999000459.SGD","IE00B031HY20.USD","LU1282651048.USD","LU0348805143.USD","LU1008478684.HKD","LU1023057109.AUD","LU0251143458.SGD","LU2125910500.SGD","LU0052756011.USD","BK4524","LU0791590937.USD","IE00BVYPNQ40.USD","LU0043850808.USD","IE0009570106.USD","LU0417516902.SGD","LU1224709979.USD","SGXZ81514606.USD","BK1129","LU0531970944.HKD","LU0348825331.USD","LU1880383440.USD","LU1152091754.HKD","LU0588546209.SGD","LU0541501648.USD","LU1267930227.SGD","LU2357305700.SGD","LU0029875118.USD","LU2008162690.USD","ACGBY","LU2152927971.USD","IE00BQXX3D17.EUR","BK0214","LU0261947096.USD","LU1497733557.USD","01378","IE0008369823.USD","LU1568876335.HKD","LU2449936058.SGD","IE0008368742.USD","LU0831103253.SGD","LU1226287792.SGD","LU0608807433.USD","LU0823038988.USD","LU1769817096.USD","LU0588545490.SGD","LU1316542783.SGD","LU0650527681.SGD","LU1880398471.USD","LU1720051017.SGD","LU0979878070.USD","HK0000306701.USD","BK4220","LU2097828631.EUR","IE00B8HQ1Z84.USD","LU0828237510.HKD","601288","LU0128522744.USD","LU0633140560.USD","LU1785774172.SGD","IE00BMPRXR70.SGD","IE0032834883.USD","BK1584","LU0197773673.USD","LU0648948544.HKD","LU1634259391.SGD","LU0175139822.USD","LU2125910849.SGD","LU2237443465.HKD","LU0648000940.SGD","LU0370786039.SGD","LU3063872942.SGD","LU1282651121.HKD","SGXZ49509284.SGD","LU0516422366.SGD","LU0169518387.USD","LU1868838027.USD","SG9999006514.SGD","00700","LU0096374516.USD","LU0140636845.USD","IE00B0JY6N72.USD","LU1105468828.SGD","LU1831875114.USD","LU0345776255.USD","LU2237443978.SGD","LU1951186391.HKD","LU2097828805.USD","HK0000165453.HKD","LU0196878994.USD","LU1064130708.USD","LU1242518931.SGD","BK1609","LU0127658192.USD","LU0456846285.SGD","BK4581","LU1880398554.USD","BK1521","LU0702159699.USD","LU1868837722.USD","BK1142","LU0577902454.USD","LU0070217475.USD","LU0320764599.SGD","LU2097828557.USD","LU0214875030.USD","LU0348783662.USD","LU0675040207.SGD","IE0003895053.USD","LU1211504680.USD","IE00BQXX3F31.USD","LU0823426480.USD","LU0143863784.USD","LU2362541273.HKD","IE00B8L5B284.USD","LU0203347892.USD","LU0516422440.USD","LU0054450605.USD","LU0130518102.USD","LU0348827113.USD","SG9999015945.SGD","LU0862451837.USD","LU0878005551.USD","HK0000252160.HKD","LU0149534421.HKD","LU2177674079.SGD","688347","BK1586","LU0918141705.HKD","BK4531","BK1560","BK1095","BK4538","IE00BF5LJ272.USD","LU1003077747.HKD","LU1719994722.HKD","LU1226288097.SGD","LU0106259558.USD","LU0329678170.USD","LU0611395673.USD","LU2317271919.USD","LU1051769294.HKD","IE00BYV24P56.USD","LU1497734951.SGD","LU0593848301.USD","LU1102505762.USD","LU0348783233.USD","LU0762542818.HKD","LU0359202008.SGD","SG9999003461.SGD","BK4554","LU0231483743.USD","BK1517","SG9999001069.SGD","BK1516","LU0264606111.USD","LU0545039389.USD","LU1808992512.USD","LU0516422952.EUR","LU0972618739.USD","BABA","IE00B0169N27.USD","LU0348723411.USD","LU0708995583.HKD","LU1323998911.USD","HTCD.SI","LU1328277881.USD","LU0501845795.SGD","LU0607220059.USD","SG9999002562.SGD","LU1224444064.USD","LU0630378692.HKD","LU0886674414.USD","IE00BGHQDM52.EUR","LU0307460666.USD","BK1589","LU0588545730.USD","IE00BMPRXN33.USD","01398","LU1226287529.USD","LU2399975544.HKD","LU1655091459.SGD","LU0210533765.USD","LU0417516571.SGD","LU0823397103.USD","SG9999004220.SGD","LU1917777945.USD","LU0985320562.USD","LU1718418525.SGD","LU0203345920.USD","LU0235996351.USD","SG9999018857.SGD","LU0210526637.USD","IE00BPRC5H50.USD","LU1303224171.USD","LU1981816686.USD","LU1497733631.SGD","LU1770036033.HKD","LU0449509016.USD","LU1282649810.SGD","LU0132412106.USD","LU0642271901.SGD","LU0540923850.HKD","LU1251922891.USD","LU0128525689.USD","LU0856984785.SGD","BK1500","LU0080751232.USD","LU0049112450.USD","LU0345769631.USD","IE00BZ08YR35.GBP","IE0003851619.USD","HXXD.SI","SG9999001903.USD","LU0228659784.USD","LU0708995153.HKD","IE00B97KM107.HKD","BK1190","BK1191","LU0228367735.SGD","LU0594300419.USD","09988","LU1048596156.SGD","LU1993786604.SGD","BK4504","002460","LU0048580855.USD","LU0572944931.SGD","LU1046421795.USD","BK1591","SGXZ99366536.SGD","LU0873338254.USD","LU2133065610.SGD","LU0791591158.USD","LU2293587155.HKD","IE0001KFT4U8.USD","LU0244354667.USD","LU0880133367.SGD","LU0084288322.USD","LU0683595622.HKD","LU0348814723.USD","LU0192582467.USD","LU0572939691.SGD","LU0502904849.HKD","LU1226288253.USD","LU0543330483.HKD","LU1051768304.USD","LU1235295612.USD","LU1115378108.SGD","LU0865486749.SGD","LU0165289439.USD","BK1526","LU0499858438.USD","LU0181495838.USD","LU0348784397.USD","LU0633140727.USD","LU1044874839.SGD","LU0052750758.USD","LU2097828474.EUR","BK1231","LU0417516738.SGD","80883","SG9999014914.USD","BK4543","LU0823426308.USD","LU0868486357.SGD","LU0039217434.USD","BK4534","LU0384037296.USD","LU2106854487.HKD","SG9999001846.SGD","LU0310800965.SGD","BK4535","LU1814569148.SGD","LU2279701549.SGD","LU0661504455.SGD","LU1226287875.USD","HBBD.SI","BK1175","LU2051468812.USD","LU0577902298.EUR","LU0149721374.USD","IE00B3M56506.USD","LU2362540622.SGD","LU1688375341.USD","LU0049853897.USD","LU1629966141.USD","LU0047713382.USD","LU1807302812.USD","600941","SG9999015986.USD","LU1794554557.SGD","81810","LU0117841782.USD","LU0572940350.SGD","IE00B543WZ88.USD","LU0762540952.USD","HK0000320223.HKD","LU0106959298.USD","SGXZ31699556.SGD","LU0516423174.USD","LU1366334578.USD","BK1502","01093","BK1531","BK1501","SG9999001051.SGD","LU1064131003.USD","SG9999006597.SGD","SGXZ81163826.USD","LU1166156734.SGD","LU0737861772.HKD","IE00BQXX3C00.GBP","LU0823041008.USD","LU0882747503.HKD","LU0287142896.SGD","IE00BVYPNP33.GBP","LU0700851271.USD","GB00BDT5M118.USD","LU1675838814.USD","BK1515","LU0431992006.USD","LU2778985437.USD","LU0117844026.USD","LU1960683339.HKD","LU0328353924.USD","LU1196710195.USD","LU0414403682.SGD","LU0594300179.USD","LU2023250504.SGD","LU0651946864.USD","LU0630378429.USD","LU1044876610.USD","LU0051755006.USD","HK0000320264.USD","IE0003795394.USD","LU1883866441.USD","LU0289960550.SGD","LU1235294995.USD","LU0762541174.USD","LU0359201612.USD","BK4579","SG9999007991.SGD","LU0348735423.USD","SG9999000418.SGD","LU1196710864.SGD","LU0164865239.USD","03143","LU0315178854.USD","01288","IE0008368304.USD","LU1733274390.USD","LU1048588211.SGD","LU2237443622.USD","LU1242518857.USD","BK1610","LU0211977185.USD","LU0509642566.USD","LU0293314216.USD","LU1515016050.SGD","BK4575","BK4527","LU1504937902.USD","LU0210527791.USD","LU0577902371.SGD","LU0456842615.SGD","SG9999001093.SGD","BK4533","LU0456827905.SGD","688981","LU0106252389.USD","LU0197773160.USD","LU1720050803.USD","IE00BZ08YS42.EUR","LU0819121731.USD","LU0229945570.USD","IE00B5MMRT66.SGD","LU0029874905.USD","LU0326950275.SGD","LU1328615791.USD","LU0163747925.USD","LU1439102457.SGD","LU2097829019.USD","LU0488056044.USD","LU2247934214.USD","00981","BK1614","BK4588","LU0477156797.USD","IE0032431581.USD","LU1720051108.HKD","LU0164880469.USD","LU1734074674.USD","BK1618","LU0128522157.USD","LU0821914370.USD","LU0561508036.HKD","LU1769817179.HKD","LU0326948709.USD","BK1588","IE00BGV7N243.SGD","LU0072913022.USD","LU1522347837.USD","LU1548497426.USD","LU2226246903.HKD","LU1152091168.USD","LU0329678337.USD","LU0862451753.SGD","LU1201861165.SGD","LU1770034418.SGD","LU0828238088.HKD","BK4122","IE0034224299.USD","LU1188198961.HKD","LU2087589342.USD","LU2242644610.SGD","IE00B29SXG58.USD","LU0651947912.USD","MIUmain","LU2251237306.USD","LU1961090484.USD","LU0315179316.USD","LU0441854154.USD","LU1568876251.USD","BK1149","LU1813983027.USD","LU0949170772.SGD","LU0449515922.USD","LU0348788117.USD","BK1506","IE00B031J352.USD","BK1536","601398","BK1523","LU1733274473.HKD","LU2498475776.HKD","LU0061477393.USD","LU0164872284.USD","LU0823040885.USD","LU0455707207.USD","LU1880383366.USD","LU0143863198.USD","TCEHY","LU1974910355.USD","LU2045819591.USD","BK4548","LU0823413660.USD","LU1102505929.USD","LU1044875133.USD","LU0130103400.USD","LU0345769128.USD","LU0737861699.HKD","LU1048484197.HKD","LU1366334651.USD","BK4565","LU0499858602.USD","LU0738911758.USD","LU1956131251.USD","LU0871576103.HKD","LU1282648689.USD","LU2237443549.SGD","LU1634259557.SGD","IE00BZ08YT58.USD","IE00BFMHRM44.USD","LU0516423091.SGD","LU0188438112.USD","LU0251144936.SGD","LU0608807946.USD","LU0823413587.USD","LU0828237940.HKD","LU0054237671.USD","BK1607","LU0173614495.USD","LU0048597586.USD","SG9999002828.SGD","LU0672654166.SGD","BK1249","LU1046422090.SGD","BK1592","LU2148510915.USD","LU1196710351.USD","IE00B0169L03.USD","LU0797268264.HKD","IE00B031HW06.USD","IE0031814852.USD","LU0543330566.HKD","BK4607","LU2362541513.USD","LU1725190679.HKD","SG9999015978.USD","LU1642822792.SGD","LU0048388663.USD","LU2237443382.USD","LU2237443895.HKD","LU0784639295.USD","LU0541502299.USD","SG9999014898.SGD","LU0634319403.HKD","LU1823568750.SGD","LU0640798160.USD","LU0011963245.USD","BK1575","LU2148611432.USD","LU0531971595.HKD","601869","LU0345775950.USD","LU0588545904.SGD","LU0605514214.HKD","LU0577902538.SGD","LU0890818403.SGD","LU0259732245.USD","LU2039709279.SGD","LU0067412154.USD","LU0878004406.USD","SG9999014880.SGD"],"gpt_icon":1},{"id":"2593763144","title":"资本涌入、合作爆发，AI制药迈入加速发展期｜记“医”2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2593763144","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593763144?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:04","pubTimestamp":1766570656,"startTime":"0","endTime":"0","summary":"在技术突破的推动下，全球AI制药行业正呈现多点开花的发展态势。摩熵投融资数据显示，今年以来，全球AI制药相关投融资事件近80起。随着技术与资本的双重加持，AI制药有望加速创新药物问世，为全球患者带来新的治疗希望。目前，全球十大制药巨头均已布局AI。另外，据国金证券统计，截至2025年11月21日，今年全球AI制药BD交易已达12项。万联证券指出，企业合作共担风险有利于推动AI制药从“概念”走向“现金流”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224180826a6c9e1e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224180826a6c9e1e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1191","03696","BK1574","01093"],"gpt_icon":1},{"id":"2594409238","title":"每日卖空追踪 | 石药集团 12月24日卖空量成交5072.8万股，卖空比例为39.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409238","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409238?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565017,"startTime":"0","endTime":"0","summary":"石药集团北京时间12月24日，跌1.24%，卖空量成交5072.8万股，较上一交易日减少42.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163229a4727dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163229a4727dc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0315179316.USD","LU1008478684.HKD","LU0326950275.SGD","LU1226288253.USD","IE0008369823.USD","LU0140636845.USD","LU1152091754.HKD","LU1226288170.HKD","LU1960683339.HKD","LU1152091168.USD","LU1951186391.HKD","BK1515","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","LU1813983027.USD","01093","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU2039709279.SGD","LU0314109678.HKD","LU1328277881.USD","LU0067412154.USD","BK1521","BK1191","LU0501845795.SGD","LU1226287875.USD","SG9999004220.SGD","IE00B031HY20.USD","LU0880133367.SGD","LU1993786604.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","IE0008368742.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0331},{"period":"1month","weight":0.1013},{"period":"3month","weight":-0.1124},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.8836},{"period":"ytd","weight":0.0059}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0296},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3422},{"period":"ytd","weight":0.0276}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品（包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片）、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.005474},{"month":2,"riseRate":0.741935,"avgChangeRate":0.096733},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}